Form 4 for INSP Inspire Medical Systems, Inc.
Accepted 2021-09-30 00:00:00 ET · period of report 2021-09-28 · accession 0001104659-21-121240 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-09-30 | 2021-09-28 | INSP | Buchholz Richard | CFO | M - OptEx | $20.46 | +4,755 | 62.3K | +8% | +$97.3K |
| DM | 2021-09-30 | 2021-09-28 | INSP | Buchholz Richard | CFO | M - OptEx | $0.00 | -4,755 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-28 | M | A | 1,607 | $42.15 | 59,476 | D | — | — | (F1) Includes 80 shares acquired under the Company's 2018 Employee Stock Purchase Plan since the date of the reporting person's last ownership report. |
| 2 | Common | Common Stock | 2021-09-28 | M | A | 329 | $0.94 | 62,624 | D | — | — | |
| 3 | Common | Common Stock | 2021-09-28 | M | A | 2,819 | $10.38 | 62,295 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2021-09-28 | M | D | 1,607 | $0.00 | 9,852 | D | $42.15 · — to 2028-12-18 | 1,607 Common Stock | (F2) The option vested and became exercisable as to 25% of the original 25,000 underlying shares on December 18, 2019 and has vested or will vest and become exercisable with respect to the remaining 75% of the original underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. |
| 5 | Derivative | Stock Option (Right to Buy) | 2021-09-28 | M | D | 2,819 | $0.00 | 3,290 | D | $10.38 · — to 2028-04-09 | 2,819 Common Stock | (F3) The option vested and became exercisable as to 25% of the original 22,556 underlying shares on April 9, 2019 and has vested or will vest and become exercisable with respect to the remaining 75% of the original underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. |
| 6 | Derivative | Stock Option (Right to Buy) | 2021-09-28 | M | D | 329 | $0.00 | 0 | D | $0.94 · — to 2027-04-01 | 329 Common Stock | (F4) The option is fully vested and exercisable. |